Related references
Note: Only part of the references are listed.Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution
Alexandra Doehring et al.
PHARMACOGENETICS AND GENOMICS (2009)
A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases
Jian Wang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
No influence of ABCB1 haplotypes on methadone dosage requirement
S. Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The coding-synonymous polymorphism rs1045280 (Ser280Ser) in β-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia
Y. -J. Liou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Modulation of voluntary ethanol consumption by beta-arrestin 2
K. Bjork et al.
FASEB JOURNAL (2008)
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
Orna Levran et al.
HUMAN MOLECULAR GENETICS (2008)
Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
Severine Crettol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy
Buster Mannheimer et al.
THERAPEUTIC DRUG MONITORING (2008)
β-Arrestins 1 and 2 are associated with nicotine dependence in European American smokers
D. Sun et al.
MOLECULAR PSYCHIATRY (2008)
Promoter polymorphism and expression of β-arrestin 2 in neutrophils
Xiaozhu Zhang et al.
CLINICA CHIMICA ACTA (2007)
Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment
Jose Perez de los Cobos et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
5′ UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism
Dai-Jin Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers
C. B. Eap et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia
M. Ikeda et al.
GENES BRAIN AND BEHAVIOR (2007)
In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R, S)-methadone, LAAM and their main metabolites
Severine Crettol et al.
PHARMACOLOGY (2007)
Evaluation of 227 drugs for in vitro inhibition of cytochrome P4502B6
Robert L. Walsky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
ABCB1 and cytochrome P450 genotypes and phenotypes:: Influence on methadone plasma levels and response to treatment
Severine Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
Janet K. Coller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments
Daniel T. Barratt et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
Decreased morphine analgesia in rat overexpressing β-arrestin 2 at periaqueductal gray
Baohong Jiang et al.
NEUROSCIENCE LETTERS (2006)
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice
RD Bruce et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
S Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Clinical response to morphine in cancer patients and genetic variation in candidate genes
JR Ross et al.
PHARMACOGENOMICS JOURNAL (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Rational inferences about departures from Hardy-Weinberg equilibrium
JK Wittke-Thompson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments
MJ Kreek et al.
PHARMACOLOGICAL REVIEWS (2005)
β-arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids
A Bradaïa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo
M Hirvonen et al.
MOLECULAR PSYCHIATRY (2004)
Desensitization of G protein-coupled receptors and neuronal functions
RR Gainetdinov et al.
ANNUAL REVIEW OF NEUROSCIENCE (2004)
Association between dopamine receptor D1 gene DdeI polymorphism and sensation seeking in alcohol-dependent men
F Limosin et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
JB Duan et al.
HUMAN MOLECULAR GENETICS (2003)
History and current status of opioid maintenance treatments: blending conference session
MJ Kreek et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2002)
The structure of haplotype blocks in the human genome
SB Gabriel et al.
SCIENCE (2002)
Interindividual variability of the clinical pharmacokinetics of methadone - Implications for the treatment of opioid dependence
CB Eap et al.
CLINICAL PHARMACOKINETICS (2002)
Genetic association studies of alcoholism - Problems with the candidate gene approach
PR Buckland
ALCOHOL AND ALCOHOLISM (2001)
Direct binding of β-arrestins to two distinct intracellular domains of the δ opioid receptor
B Cen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
LM Bohn et al.
NATURE (2000)
Genetic association studies of bronchial asthma - a need for Bonferroni correction?
S Boehringer et al.
HUMAN GENETICS (2000)
Share Paper
